Literature DB >> 8668173

Requirements for interleukin 2 promoter transactivation by the Tax protein of human T-cell leukemia virus type 1.

V E Curtiss1, R Smilde, K L McGuire.   

Abstract

The Tax protein of human T-cell leukemia virus type 1 (HTLV-1) upregulates the expression of several cellular genes by activating members of both the NF-kappaB and bZIP families of transcription factors. Recent studies demonstrate that the CD28 response element (CD28RE) of the interleukin 2 (IL-2) promoter is the site upregulated by Tax in stimulated T cells. Although some reports suggest that this site is transactivated by NF-kappaB family members, others disagree, leaving the identity of the transcription factor(s) binding the CD28RE unclear. The studies presented here further characterize the response of the IL-2 promoter and CD28RE to the HTLV-1 Tax protein and demonstrate that the TATA-proximal AP-1 binding site of the IL-2 promoter is also necessary for Tax transactivation in stimulated Jurkat cells. In contrast to its upregulation of the IL-2 promoter which requires T-cell stimulation, Tax transactivates the isolated CD28RE-AP-1 element without stimulation but is greatly synergized by calcium ionophore and phorbol ester. Additionally, transactivation of the IL-2 promoter requires the Tax activation domain involved in upregulation of bZIP-enhanced transcription while the NF-kappaB-activating domain of Tax is dispensable. Interestingly, both domains appear to be necessary for the activation of the isolated CD28RE-AP-1 sequence in the context of a heterologous promoter construct. This strongly suggests that activation of NF-kappaB is insufficient to activate transcription via the CD28RE-AP-1 element of the IL-2 promoter and that a different transcription factor, upregulated via the activation domain of the HTLV-1 Tax protein, may be involved.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8668173      PMCID: PMC231352          DOI: 10.1128/MCB.16.7.3567

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  61 in total

1.  The interleukin 2 CD28-responsive complex contains at least three members of the NF kappa B family: c-Rel, p50, and p65.

Authors:  P Ghosh; T H Tan; N R Rice; A Sica; H A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

2.  Evidence for a role of CD28RE as a response element for distinct mitogenic T cell activation signals.

Authors:  A Civil; M Geerts; L A Aarden; C L Verweij
Journal:  Eur J Immunol       Date:  1992-11       Impact factor: 5.532

3.  Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction.

Authors:  L J Zhao; C Z Giam
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

4.  Direct interaction of CREB protein with 21 bp Tax-response elements of HTLV-ILTR.

Authors:  P Beimling; K Moelling
Journal:  Oncogene       Date:  1992-02       Impact factor: 9.867

5.  The transcriptionally active factors mediating the effect of the HTLV-I Tax transactivator on the IL-2R alpha kappa B enhancer include the product of the c-rel proto-oncogene.

Authors:  I Crenon; C Béraud; P Simard; J Montagne; P Veschambre; P Jalinot
Journal:  Oncogene       Date:  1993-04       Impact factor: 9.867

6.  Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28.

Authors:  J D Fraser; A Weiss
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

7.  Influence of human T-cell leukemia virus type I tax and rex on interleukin-2 gene expression.

Authors:  K L McGuire; V E Curtiss; E L Larson; W A Haseltine
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

8.  A cis element required for induction of the interleukin 2 enhancer by human T-cell leukemia virus type I binds a novel Tax-inducible nuclear protein.

Authors:  M Li; M Siekevitz
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

9.  HTLV-I encoded Tax in association with NF-kappa B precursor p105 enhances nuclear localization of NF-kappa B p50 and p65 in transfected cells.

Authors:  M Watanabe; M Muramatsu; H Hirai; T Suzuki; J Fujisawa; M Yoshida; K Arai; N Arai
Journal:  Oncogene       Date:  1993-11       Impact factor: 9.867

10.  The trans-activator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1.

Authors:  T Suzuki; J I Fujisawa; M Toita; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

View more
  5 in total

1.  HTLV-I Tax self-association in optimal trans-activation function.

Authors:  D Y Jin; K T Jeang
Journal:  Nucleic Acids Res       Date:  1997-01-15       Impact factor: 16.971

2.  Molecular interactions involved in the transactivation of the human T-cell leukemia virus type 1 promoter mediated by Tax and CREB-2 (ATF-4).

Authors:  F Gachon; S Thebault; A Peleraux; C Devaux; J M Mesnard
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

3.  Triple synergism of human T-lymphotropic virus type 1-encoded tax, GATA-binding protein, and AP-1 is required for constitutive expression of the interleukin-5 gene in adult T-cell leukemia cells.

Authors:  T Yamagata; K Mitani; H Ueno; Y Kanda; Y Yazaki; H Hirai
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

4.  Acetylation of nucleosomal histones by p300 facilitates transcription from tax-responsive human T-cell leukemia virus type 1 chromatin template.

Authors:  Hanxin Lu; Cynthia A Pise-Masison; Terace M Fletcher; R Louis Schiltz; Akhilesh K Nagaich; Michael Radonovich; Gordon Hager; Philip A Cole; John N Brady
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

5.  The HBZ-SP1 isoform of human T-cell leukemia virus type I represses JunB activity by sequestration into nuclear bodies.

Authors:  Patrick Hivin; Jihane Basbous; Frédéric Raymond; Daniel Henaff; Charlotte Arpin-André; Véronique Robert-Hebmann; Benoit Barbeau; Jean-Michel Mesnard
Journal:  Retrovirology       Date:  2007-02-16       Impact factor: 4.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.